NO803684L - Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalinderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalinderivater.

Info

Publication number
NO803684L
NO803684L NO803684A NO803684A NO803684L NO 803684 L NO803684 L NO 803684L NO 803684 A NO803684 A NO 803684A NO 803684 A NO803684 A NO 803684A NO 803684 L NO803684 L NO 803684L
Authority
NO
Norway
Prior art keywords
quinoxaline
hydrogen
amino
bound
formula
Prior art date
Application number
NO803684A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Leigh
Bernard Joseph Mcloughlin
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NO803684L publication Critical patent/NO803684L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO803684A 1979-12-06 1980-12-05 Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalinderivater. NO803684L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942090 1979-12-06

Publications (1)

Publication Number Publication Date
NO803684L true NO803684L (no) 1981-06-09

Family

ID=10509650

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803684A NO803684L (no) 1979-12-06 1980-12-05 Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalinderivater.

Country Status (8)

Country Link
EP (1) EP0030795A3 (forum.php)
JP (1) JPS5692277A (forum.php)
AU (1) AU6461080A (forum.php)
DK (1) DK514280A (forum.php)
FI (1) FI803762A7 (forum.php)
GR (1) GR82323B (forum.php)
NO (1) NO803684L (forum.php)
ZA (1) ZA807311B (forum.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
HUT76302A (en) * 1995-11-30 1997-07-28 Chinoin Gyogyszer Es Vegyeszet Quinoxaline derivatives, pharmaceutical compositions containing them and process for producing them
DE102007050673A1 (de) 2007-10-19 2009-04-23 Friedrich-Schiller-Universität Jena Neue Hexaaza-acene und Verfahren zu ihrer Herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
US4181724A (en) * 1978-09-11 1980-01-01 The Upjohn Company Quinoxalinone compounds useful for expanding the lumina or air passages in mammals

Also Published As

Publication number Publication date
GR82323B (forum.php) 1984-12-13
EP0030795A3 (en) 1981-09-09
ZA807311B (en) 1981-11-25
FI803762L (fi) 1981-06-07
DK514280A (da) 1981-06-07
EP0030795A2 (en) 1981-06-24
AU6461080A (en) 1981-06-11
FI803762A7 (fi) 1981-06-07
JPS5692277A (en) 1981-07-25

Similar Documents

Publication Publication Date Title
Lima et al. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues
AU2019280023B2 (en) Aryl receptor modulators and methods of making and using the same
JP6768857B2 (ja) リジン特異的なデメチラーゼ−1の阻害剤
RU2128172C1 (ru) Производные пиразола или их фармацевтически приемлемые соли
Kuroda et al. A novel synthesis and potent antiinflammatory activity of 4-hydroxy-2 (1H)-oxo-1-phenyl-1, 8-naphthyridine-3-carboxamides
Molvi et al. Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents
CN105272904B (zh) N-苯基酰胺类化合物及其应用
JP2006517199A5 (forum.php)
AU2008203305A1 (en) New benzimidazole derivatives
Ragab et al. Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
WO2014203217A1 (en) Substituted heterocyclic compounds as crac modulators
WO1998022442A2 (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds and their use as cyclooxygenase i (cox 1) inhibitors
NO311515B1 (no) Tetrahydrobenzindolforbindelser, og farmasöytiske preparater inneholdende slike forbindelser
US3634427A (en) (1)benzothieno(2 3-d)pyrimidine derivatives
JP5096500B2 (ja) ピペリジン誘導体
Mustière et al. Pd-catalyzed C–C and C–N cross-coupling reactions in 2-aminothieno [3, 2-d] pyrimidin-4 (3 H)-one series for antiplasmodial pharmacomodulation
NO803684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalinderivater.
JPH01106839A (ja) アルカジエン誘導体類、それらの製造、およびそれらを含有している薬学的組成物
CN108314679A (zh) 一种含1,3,4-噁二唑环二苯乙烯酰胺杀菌剂及其制备方法和应用
JP6033788B2 (ja) 置換されたメチルアミン、セロトニン5−ht6受容体アンタゴニスト、製造のための方法及びその使用
El-Ansary et al. Design, synthesis and biological evaluation of some new succinimide, 2-iminothiazoline and oxazine derivatives based benzopyrone as anticonvulsant agents
NO142346B (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive kondenserte n-fenylsubstituerte pyrroler
US4515944A (en) 1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates
CN103980289B (zh) 噻吩并噻喃并吡唑类化合物及其医药应用
NZ566831A (en) Salts of modulators of PPAR and methods of treating metabolic disorders